Clinical research and trials in stem cells and cancer


Clinical preliminaries are broadly observed for real advances in Cancer treatment because of developing new medications to avert or help oversee Graft-Versus-Host Disease (GvHD). Graft-Versus-Host Disease a typical and conceivably extreme reaction of stem cell transplants in which contributor safe cells attack solid patient cells and tissues. Creating cancer immunization systems for use alongside transplant to invigorate the Graft-Versus- leukaemia (GVL) impact and limit malady backslide. Graft-versus-Leukaemia has restorative impact in which transplanted invulnerable cells attack leftover leukaemia or other tumour cells


  • Cellular therapy
  • Tissue regeneration
  • Drug discovery

Related Conference of Clinical research and trials in stem cells and cancer

July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 25-26, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada
December 21-22, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE

Clinical research and trials in stem cells and cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in